Vuong Trieu, CSO, Director at Sorrento Therapeutics, holds 115.70M shares in Oncotelic Therapeutics (Ticker: OTLC), holds 3.01M shares in Sorrento Therapeutics (Ticker: SRNE). Most recently, Vuong Trieu Bought ― shares of Oncotelic Therapeutics on Jun 30, 2023 for an estimated value of 10.00K.